[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Patients after evaluation and confirmation of Covid 19 and having entry conditions,Enter the study and then patients are divided into two groups A and B based on simple randomization method.In the first group, patients receive Ramdzivir 200 mg loading dose and then 100 mg intravenously daily for up to 5 days. In addition, they receive mulnopiravir at a dose of 200 mg every 12 hours for up to 5 days.In the second group, Ramdzivir receive the said dose plus placebo every 12 hours for up to 5 days.The rest of the drugs used by the patients are the same in the two groups, then the general condition of the patients, tests and CT scans of the patients are checked.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2105, "treatment_name": "Molnupiravir+remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}]